STOCKWATCH
·
Pharmaceuticals
Joint Venture6 Feb 2026, 02:02 am

Piramal Critical Care and Blue-Zone Technologies Collaborate to Capture, Collect and Recycle Waste Anaesthesia Gas

AI Summary

Piramal Critical Care, Inc. (PCC) and Blue-Zone Technologies Ltd. (Blue-Zone) have announced an agreement to collaborate on full lifecycle technology to capture and recycle waste anaesthetic gases. This collaboration will support customers’ efforts to minimize the environmental impact of volatile anaesthetics and ensure the continued use of these essential products for general anaesthesia. Pending regulatory approval in Europe, Blue-Zone will offer its Phoenix Deltasorb® waste anaesthetic gas capture system to PCC’s customers in Europe, initially in France and Germany. PCC will process captured waste anaesthetic gas using Blue- Zone’s technology to produce Sevoflurane USP for human use in Canada. The parties anticipate that the scope of the waste anaesthetic gas capture, collection and recycling, and the marketing of Sevoflurane USP using waste anaesthetic gas, will expand into additional geographies.

Key Highlights

  • Piramal Critical Care and Blue-Zone Technologies announce a collaboration to capture and recycle waste anaesthetic gases.
  • The collaboration aims to minimize the environmental impact of volatile anaesthetics and ensure the continued use of these essential products for general anaesthesia.
  • Pending regulatory approval in Europe, Blue-Zone will offer its Phoenix Deltasorb® waste anaesthetic gas capture system to PCC’s customers in Europe.
  • PCC will process captured waste anaesthetic gas using Blue- Zone’s technology to produce Sevoflurane USP for human use in Canada.
  • The parties anticipate expanding the scope of the waste anaesthetic gas capture, collection and recycling into additional geographies.
PPLPHARMA
Pharmaceuticals
Piramal Pharma Ltd

Price Impact